Literature DB >> 12451197

Primary CNS lymphoma: a whole-brain disease?

Rose Lai1, Marc K Rosenblum, Lisa M DeAngelis.   

Abstract

BACKGROUND: Autopsy studies reveal that most primary CNS lymphomas (PCNSL) extensively infiltrate the brain. To date, there has been no correlation of autopsy findings with a modern neuroimaging assessment of tumor burden.
OBJECTIVE: To correlate autopsy findings in PCNSL to MRI findings.
METHOD: From the authors' database of immunocompetent patients with PCNSL diagnosed between 1985 and 2001, 10 patients who died and had PCNSL at autopsy were identified. Their pathology was compared to MR scans obtained shortly before death.
RESULTS: The median patient age was 60 years (range 44 to 80 years). There were six men and four women. Scans were performed within 4 weeks of death in seven patients, within 3 months in two patients, and within 4 months in one. Seven had enhancing lesions consistent with recurrence, and two of the three had focal T2 abnormalities. All had periventricular white matter abnormalities on T2 MR images. At autopsy, all 10 patients had widespread lymphoma throughout the CNS, but no tumor was found systemically. All had tumor infiltration in CNS regions that were normal radiographically, including T2 sequences.
CONCLUSIONS: MRI underestimates the tumor burden of PCNSL. Bulky disease is seen as a contrast-enhancing lesion because of disruption of the blood-brain barrier, but microscopic tumor infiltration may lead to T2 hyperintensity or be completely normal radiographically.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12451197     DOI: 10.1212/01.wnl.0000034256.20173.ea

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  41 in total

Review 1.  New approaches in primary central nervous system lymphoma.

Authors:  Eleanor Fraser; Katherine Gruenberg; James L Rubenstein
Journal:  Chin Clin Oncol       Date:  2015-03

Review 2.  Primary central nervous system lymphoma: essential points in diagnosis and management.

Authors:  Semra Paydas
Journal:  Med Oncol       Date:  2017-03-17       Impact factor: 3.064

3.  Neurocognitive features distinguishing primary central nervous system lymphoma from other possible causes of rapidly progressive dementia.

Authors:  Mariel B Deutsch; Mario F Mendez
Journal:  Cogn Behav Neurol       Date:  2015-03       Impact factor: 1.600

Review 4.  Advances in Primary Central Nervous System Lymphoma.

Authors:  Lauren B Patrick; Nimish A Mohile
Journal:  Curr Oncol Rep       Date:  2015-12       Impact factor: 5.075

Review 5.  Primary pituitary lymphoma: an update of the literature.

Authors:  A Tarabay; G Cossu; M Berhouma; M Levivier; R T Daniel; M Messerer
Journal:  J Neurooncol       Date:  2016-08-31       Impact factor: 4.130

Review 6.  Primary T cell central nervous system lymphoblastic lymphoma in a child: case report and literature review.

Authors:  Marcus D Mazur; Vijay M Ravindra; Mouied Alashari; Elizabeth Raetz; Matthew M Poppe; Robert J Bollo
Journal:  Childs Nerv Syst       Date:  2015-02-15       Impact factor: 1.475

Review 7.  Rapidly progressive dementia.

Authors:  Michael D Geschwind; Huidy Shu; Aissa Haman; James J Sejvar; Bruce L Miller
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

Review 8.  Primary central nervous system lymphoma.

Authors:  Igor T Gavrilovic; Lauren E Abrey
Journal:  Curr Oncol Rep       Date:  2004-09       Impact factor: 5.075

9.  Post-treatment T1 shortening in primary CNS lymphoma.

Authors:  Sasan Karimi; Vaios Hatzoglou; Vineet Punia; Sasan Partovi; Lauren E Abrey; Lisa M Deangelis
Journal:  J Neurooncol       Date:  2012-10-17       Impact factor: 4.130

Review 10.  Treatment of primary central nervous system lymphoma.

Authors:  Meltem Ekenel; Lisa M DeAngelis
Journal:  Curr Neurol Neurosci Rep       Date:  2007-05       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.